AAAAAA

   
Results: 1-10 |
Results: 10
Quality specifications for cardiac troponin assays
Authors: Panteghini, M Gerhardt, W Apple, FS Dati, F Ravkilde, J Wu, AH
Citation: M. Panteghini et al., Quality specifications for cardiac troponin assays, CLIN CH L M, 39(2), 2001, pp. 175-179
International survey on the use of cardiac markers
Authors: Apple, FS Murakami, M Panteghini, M Christenson, RH Dati, F Mair, J Wu, AHB
Citation: Fs. Apple et al., International survey on the use of cardiac markers, CLIN CHEM, 47(3), 2001, pp. 587-588
Analytical and clinical evaluation of troponin I determination on Dimension RxL-HM
Authors: Hafner, G Peetz, D Dati, F Post, F Blankenberg, S Peivandi, AA Sucke, B Rupprecht, HJ Dahm, M von Kleist, R Prellwitz, W
Citation: G. Hafner et al., Analytical and clinical evaluation of troponin I determination on Dimension RxL-HM, CLIN CH L M, 38(4), 2000, pp. 355-361
Use of a reference material proposed by the international federation of clinical chemistry and laboratory medicine to evaluate analytical methods forthe determination of plasma lipoprotein(a)
Authors: Marcovina, SM Albers, JJ Scanu, AM Kennedy, H Giaculli, F Berg, K Couderc, R Dati, F Rifai, N Sakurabayashi, I Tate, JR Steinmetz, A
Citation: Sm. Marcovina et al., Use of a reference material proposed by the international federation of clinical chemistry and laboratory medicine to evaluate analytical methods forthe determination of plasma lipoprotein(a), CLIN CHEM, 46(12), 2000, pp. 1956-1967
Standardization activities for harmonization of test results
Authors: Dati, F Brand, B
Citation: F. Dati et B. Brand, Standardization activities for harmonization of test results, CLIN CHIM A, 297(1-2), 2000, pp. 239-249
Use of biochemical markers in acute coronary syndromes
Authors: Panteghini, M Apple, FS Christenson, RH Dati, F Mair, J Wu, AH
Citation: M. Panteghini et al., Use of biochemical markers in acute coronary syndromes, CLIN CH L M, 37(6), 1999, pp. 687-693
International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) standardization project for the measurement of lipoprotein(a). Phase 2:Selection and properties of a proposed secondary reference material for lipoprotein(a).
Authors: Tate, JR Berg, K Couderc, R Dati, F Kostner, GM Marcovina, SM Rifai, N Sakurabayashi, I Steinmetz, A
Citation: Jr. Tate et al., International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) standardization project for the measurement of lipoprotein(a). Phase 2:Selection and properties of a proposed secondary reference material for lipoprotein(a)., CLIN CH L M, 37(10), 1999, pp. 949-958
Proposals from IFCC Committee on Standardization of Markers of Cardiac Damage (C-SMCD): Recommendations on use of biochemical markers of cardiac damage in acute coronary syndromes
Authors: Panteghini, M Apple, FS Christenson, RH Dati, F Mair, J Wu, AH
Citation: M. Panteghini et al., Proposals from IFCC Committee on Standardization of Markers of Cardiac Damage (C-SMCD): Recommendations on use of biochemical markers of cardiac damage in acute coronary syndromes, SC J CL INV, 59, 1999, pp. 103-112
Proposals from the IFCC Committee on Standardization of Markers of CardiacDamage (C-SMCD): Strategies and concepts on standardization of cardiac marker assays
Authors: Dati, F Panteghini, M Apple, FS Christenson, RH Mair, J Wu, AH
Citation: F. Dati et al., Proposals from the IFCC Committee on Standardization of Markers of CardiacDamage (C-SMCD): Strategies and concepts on standardization of cardiac marker assays, SC J CL INV, 59, 1999, pp. 113-123
Relevance of markers of hemostasis activation in obstetrics/gynecology andpediatrics
Authors: Dati, F Pelzer, H Wagner, C
Citation: F. Dati et al., Relevance of markers of hemostasis activation in obstetrics/gynecology andpediatrics, SEM THROMB, 24(5), 1998, pp. 443-448
Risultati: 1-10 |